INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2019

Soy milk alongside a calorie-restricted diet reduced serum ALT and hs-CRP more than diet alone in patients with NAFLD.

A parallel randomized clinical trial evaluated the effect of consuming 240 ml of soy milk daily as part of a 500-calorie deficit diet compared to the deficit diet alone for 8 weeks in 70 patients with NAFLD. The soy milk group showed significantly greater reductions in serum alanine aminotransferase (-12.06 ± 17.61 IU/L vs. -5 ± 8.58 IU/L, p = 0.04) and hs-CRP (-1.32 ± 1.60 mg/L vs. -0.36 ± 1.54 mg/L, p = 0.01). However, changes in fatty liver grade, other liver enzymes (AST, ALP, GGT), lipid profiles, and anthropometric indices did not differ significantly between groups.

Study type
Parallel randomized clinical trial
Who was studied
70 patients with nonalcoholic fatty liver disease (NAFLD)
What was measured
Grade of fatty liver, liver enzymes, lipid profile, serum hs-CRP, and anthropometric indices

THE PAPER

Effect of Soy Milk on Metabolic Status of Patients with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Eslami O, Shidfar F, Maleki Z, Jazayeri S, Hosseini AF, Agah S, Ardiyani F. J Am Coll Nutr, 2019.

PubMed 30028245 ↗DOI 10.1080/07315724.2018.1479990 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.